Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BQ.1.1.56EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.59EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.67EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.2.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.88EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.48EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.34.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JD.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.79EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HP.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FU.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EY.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.35EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EL.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.44EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FU.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EF.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.84EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EU.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.97EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FE.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.3.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.95EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
ET.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.34EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.31EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.42EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.5.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.31EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.41EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.46EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CP.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used